Advertisement
Advertisement
Hansoh Pharmaceutical
TOPIC
 / company

Hansoh Pharmaceutical

Hansoh Pharmaceutical
Hansoh Pharmaceutical
Hansoh Pharmaceutical is China's largest maker of psychotropic medication by sales. The company also researches and produces medications in areas of oncology, anti-infections, central nervous system diseases, metabolic diseases and autoimmune diseases. It was founded by Zhong Huijuan, China's third richest woman and wife of Sun Piaoyang, chairman of prominent anti-tumour medication maker Jiangsu Hengrui Medicine.
Chairman / President
Zhong Huijuan
CEO / Managing Director
Zhong Huijuan
CFO / Finance Director
HU Min
Industry
Health & Pharmaceuticals
Website
hspharm.com
Headquarters address
No. 3 Guangming Road, Lianyungang, Jiangsu, China
Stock Code
SEHK:03692
Year founded
1995
LATEST China Science NEWS

Don’t panic if you see a snake on a Chinese power line. It might be a robot

The robotic snake’s head is equipped with a camera and sensors to identify safety hazards, while the tail has a power harvesting device that lets it draw power from the lines it is inspecting. Photo: qq.com

Starlink rival Qianfan hits satellite milestone, but is it too slow and costly?

7
A Long March-12B Y1 rocket blasts off from the Dongfeng Commercial Space Innovation Pilot Zone on June 1, carrying satellites for the Qianfan constellation. Photo: Xinhua

China delivers first samples collected from far side of the moon to Russia

videocam
The Chang’e-6 mission was the first to collect samples from the far side of the moon. Photo: AP

China’s rail gun milestone: guided projectile prototype passes real firing test

videocam
8
A prototype of a chip-protecting component for China’s guided rail gun shell used in a live firing test. Photo: North University of China

China performs world’s first combined transplant of pig liver and kidney to human

videocam
Despite the potential of animal-to-human xenotransplantation, there are still many barriers scientists and doctors have to overcome before it can become a clinical practice. Photo: Universal Images Group via Getty Images
MORE China Science NEWS
Chinese pharmaceutical companies may expand into international markets in the coming years. Photo: Shutterstock
China’s private sector

Which company could become the Chinese Pfizer? Here are analysts’ top picks

A boom in outlicensing agreements leads to a debate over which Chinese firms may be first to break into overseas markets with own brands.

Hong Kong stock market

China AI firms Zhipu, MiniMax to join Hong Kong’s Hang Seng Tech Index

videocam
Banking & finance

China healthcare stocks shine in Hong Kong amid Middle East turmoil

China’s private sector

China’s obesity drug makers take on global giants as Novo Nordisk patent expires

Patent expiry of blockbuster drug opens door for Chinese drug makers to challenge multinationals in booming weight-loss market.

Semaglutide generated about US$35 billion in global revenue last year. Photo: AFP
Made in China 2025

Hong Kong-listed Chinese drug firms set to turn corner on rising sales, deals

Chinese pharmaceutical firms are poised for profit growth, driven by innovative drug sales and licensing deals, despite pricing pressures.

Science

China’s biopharma sector ‘in prime position to challenge US leadership’

American commission issues stark warning, as analytics firm Clarivate reports that Chinese innovative drug development has entered new phase.

videocam
33
Advertisement
Advertisement
Advertisement
United States

Are Chinese biotechs what the doctor ordered as Big Pharma faces ‘patent cliff’?

US drug makers are racing to plug looming ‘patent cliff’ revenue gaps – and increasingly they are turning to China biotechs.

US drugmakers are increasingly looking to Chinese biotechs as an answer to the revenue gaps left by the looming ‘patent cliff’. Illustration by Henry Wong
Made in China 2025

China’s pharmaceutical industry transforms into a global innovation powerhouse

The China Pharmaceutical Innovation and Invention Index, a new gauge, highlights top drug makers on the mainland for the first time.

China economy

Opinion | How China engineered the rapid rise of its drug innovation industry

A market once dominated by generics is now an AI-powered pharmaceutical hub drawing billion-dollar investments from the likes of Pfizer and GSK.

videocam
New medical drugs

6 of the best: the billion-dollar biotechs putting China on the map

China’s biotech renaissance is gathering pace as home-grown innovators strike billion-dollar licensing deals with global giants.

Illustration: Henry Wong
Hong Kong stock market

Hong Kong stock rally extends as investors bet on US-China trade agreement

Investors shrug off US President Donald Trump’s mention of a 155 per cent tariff on Chinese goods if negotiations fail.

A model depicting US President Donald Trump is shown in an illustration created on April 17, 2025. Photo: Reuters
Hong Kong stock market

Hong Kong stocks surge on trade optimism, China economic growth

Benchmark rebounds from last week’s loss after ‘constructive’ talk between US treasury secretary, Chinese vice-premier.

Biomedicine: Companies

Hansoh and Leads Biolabs clinch US$2.5 billion in global drug licensing deals

Two mainland biotech firms win global attention as Roche and Dianthus sign major licensing pacts, highlighting China’s growing role in next-generation drug development.

Biomedicine: Industry Trends

China’s drug developers stretch to become a global force

Although a start-up’s recent triumph is seen as a ‘DeepSeek moment’, domestic players still trail world-beating pharma firms, experts say.

10
Illustration: Henry Wong
Hong Kong stock market

Chinese biotechs get a shot in the arm from policy support, licensing deals

‘We are on an upcycle in the industry and sentiment is very strong,’ Xufunds Investment fund manager Wang Chen says.

Shares of WuXi Biologics have more than doubled year to date. Photo: Shutterstock
Banking & finance

China’s healthcare segment eyes record fundraising amid global investor surge

China biotech remains a market bright spot with strong growth, driven by out-licensing, efficiency improvements and cost control.

Hong Kong stock market

Hong Kong stocks rebound on US-China trade talk optimism

Hang Seng Index recovers from an intraday loss of as much as 0.9 per cent, snapping a four-day losing streak.

Advertisement
Advertisement
Advertisement
Biomedicine: Companies

Chinese pharma firms Hengrui, Hansoh expected to post strong first-half profits

Novel drug roll-outs and revenue from licensing buoy results.

Workers inside Hansoh Pharmaceutical. Photo: Handout
Hong Kong stock market

Rally in solar and EV stocks lifts Hong Kong benchmark to 3½-year high

Expectations are high that the July Politburo meeting will introduce more measures to eliminate excess capacity in some emerging industries.

Hong Kong stock market

Mainland investors on track to beat Hong Kong stock buying record set in 2024

Investors from the mainland buy more than US$93 billion worth of Hong Kong stocks in the first half of 2025.

Hong Kong stock market

Hong Kong stocks drop as PDD’s profit slump rattles Alibaba, e-commerce peers

PDD’s overnight slump in New York infected e-commerce stocks amid concerns price discounting will erode margins.

videocam
Exchange Square in Central, Hong Kong. Photo: Nathan Tsui
Science

The Chinese chemists turning science into fortunes

Chinese chemistry professor Fan Daidi has synthesised collagen into a commercial success.

videocam
Chemistry professor Fan Daidi, 59, has created a Hong Kong-listed giant. Photo: Handout
Hong Kong stock market

Hong Kong stocks rise even as looming Trump tariffs keep sentiment in check

The Hang Seng Index is under consolidation as traders await development on the US tariffs front, says analyst Kenny Wen.

Hong Kong stock market

Hang Seng review shines light on China’s 6th richest woman at Hansoh Pharma

Hansoh Pharmaceutical, founded by China’s sixth richest woman, rose with two other new members, before officially joining the benchmark index on September 5. Chow Tai Fook Jewellery surrendered gain.

videocam
Millionaires and billionaires

How chemistry teacher Zhong Huijuan became the world’s richest self-made woman

She’s been playfully compared to Breaking Bad’s Walter White for her career change – now the Hansoh Pharmaceutical founder is 2020’s richest self-made billionaire

Former chemistry teacher Zhong Huijuan is now the matriarch of pharmaceutical company Hansoh Pharmaceutical. Photo: Baidu
Stocks

Chem teacher behind pharmaceutical firm to be China’s third-richest woman

Zhong Huijuan will have US$7.9 billion fortune after her Hansoh Pharmaceutical Group goes public in Hong Kong on Friday

A technician loads containers on a rack at a Cyagen Biosciences facility in Jiangsu province, China, in March. Photo: Bloomberg
Advertisement
Advertisement
Advertisement
Help preserve 120 years of quality journalism.
SUPPORT NOW
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement